Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Risks from antipsychotic medications in children and adolescents.

Mangurian C, Fuentes-Afflick E, Newcomer JW.

JAMA. 2010 Feb 24;303(8):729; author reply 730. doi: 10.1001/jama.2010.131. No abstract available.

PMID:
20179279
[PubMed - indexed for MEDLINE]
2.

Risks from antipsychotic medications in children and adolescents.

Lewin AB, Storch EA, Storch HD.

JAMA. 2010 Feb 24;303(8):729-30; author reply 730-1. doi: 10.1001/jama.2010.132. No abstract available.

PMID:
20179278
[PubMed - indexed for MEDLINE]
3.

Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents.

Varley CK, McClellan J.

JAMA. 2009 Oct 28;302(16):1811-2. doi: 10.1001/jama.2009.1558. No abstract available.

PMID:
19861677
[PubMed - indexed for MEDLINE]
4.

Age-dependent metabolic effects of second-generation antipsychotics in second-generation antipsychotic-naïve French Canadian patients.

Roy G, Bedard A, Desmarais PA, Jourdain F, Allen S, Michaud D, Ben Amor L.

J Child Adolesc Psychopharmacol. 2010 Dec;20(6):479-87. doi: 10.1089/cap.2010.0011.

PMID:
21186966
[PubMed - indexed for MEDLINE]
5.

Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?

Vieweg WV, Sood AB, Pandurangi A, Silverman JJ.

Acta Psychiatr Scand. 2005 Mar;111(3):177-84.

PMID:
15701101
[PubMed - indexed for MEDLINE]
6.

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.

Kelly DL, Conley RR, Love RC, Horn DS, Ushchak CM.

J Child Adolesc Psychopharmacol. 1998;8(3):151-9.

PMID:
9853689
[PubMed - indexed for MEDLINE]
7.

Effects of second generation antipsychotics on leptin and ghrelin.

Esen-Danaci A, Sarandöl A, Taneli F, Yurtsever F, Ozlen N.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1434-8. doi: 10.1016/j.pnpbp.2008.03.015. Epub 2008 Apr 1.

PMID:
18579280
[PubMed - indexed for MEDLINE]
8.

Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.

Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B.

J Clin Psychiatry. 2006 Aug;67(8):1253-60.

PMID:
16965204
[PubMed - indexed for MEDLINE]
9.

A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.

Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA.

Am J Psychiatry. 2006 Dec;163(12):2072-9.

PMID:
17151157
[PubMed - indexed for MEDLINE]
10.

Weight gain and first-generation antipsychotics: experience from a developing country.

Yoon CK.

J Clin Psychopharmacol. 2008 Oct;28(5):574-6. doi: 10.1097/JCP.0b013e3181855cbc. No abstract available.

PMID:
18794660
[PubMed - indexed for MEDLINE]
11.

Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome.

Degrauw RS, Li JZ, Gilbert DL.

Pediatr Neurol. 2009 Sep;41(3):183-6. doi: 10.1016/j.pediatrneurol.2009.04.002.

PMID:
19664533
[PubMed - indexed for MEDLINE]
12.

Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?

Correll CU.

J Clin Psychiatry. 2005 Oct;66(10):1331-2. No abstract available.

PMID:
16259549
[PubMed - indexed for MEDLINE]
13.

Risperidone-associated weight gain in children and adolescents: a retrospective chart review.

Martin A, Landau J, Leebens P, Ulizio K, Cicchetti D, Scahill L, Leckman JF.

J Child Adolesc Psychopharmacol. 2000 Winter;10(4):259-68.

PMID:
11191686
[PubMed - indexed for MEDLINE]
14.

Adverse events in children and adolescents treated with antipsychotic medications.

Jerrell JM, McIntyre RS.

Hum Psychopharmacol. 2008 Jun;23(4):283-90. doi: 10.1002/hup.932.

PMID:
18302312
[PubMed - indexed for MEDLINE]
15.

[Challenges in nutrition-based treatment for weight control in adolescents suffering from schizophrenia].

Shani M, Levi M, Zalsman G.

Harefuah. 2008 Nov;147(11):901-5, 939. Review. Hebrew.

PMID:
19264012
[PubMed - indexed for MEDLINE]
16.

Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.

Fleischhaker C, Heiser P, Hennighausen K, Herpertz-Dahlmann B, Holtkamp K, Mehler-Wex C, Rauh R, Remschmidt H, Schulz E, Warnke A.

J Neural Transm. 2008 Nov;115(11):1599-608. doi: 10.1007/s00702-008-0105-9. Epub 2008 Sep 9.

PMID:
18779922
[PubMed - indexed for MEDLINE]
17.

Weight gain with clozapine compared to first generation antipsychotic medications.

Covell NH, Weissman EM, Essock SM.

Schizophr Bull. 2004;30(2):229-40.

PMID:
15279042
[PubMed - indexed for MEDLINE]
Free Article
18.

[Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].

Koga M.

Seishin Shinkeigaku Zasshi. 2003;105(4):473-88. Japanese.

PMID:
12806910
[PubMed - indexed for MEDLINE]
19.

Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.

Gebhardt S, Haberhausen M, Heinzel-Gutenbrunner M, Gebhardt N, Remschmidt H, Krieg JC, Hebebrand J, Theisen FM.

J Psychiatr Res. 2009 Mar;43(6):620-6. doi: 10.1016/j.jpsychires.2008.11.001. Epub 2008 Dec 24.

PMID:
19110264
[PubMed - indexed for MEDLINE]
20.

Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.

Simpson MM, Goetz RR, Devlin MJ, Goetz SA, Walsh BT.

J Clin Psychiatry. 2001 Sep;62(9):694-700.

PMID:
11681765
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk